The Ambrisentan Market is an important segment of the pharmaceutical industry focused on therapies for pulmonary arterial hypertension (PAH). Ambrisentan is an endothelin receptor antagonist used in the treatment of PAH, a serious condition involving elevated pressure in the pulmonary arteries. The U.S. Food and Drug Administration lists ambrisentan under the brand Letairis and identifies its...